Fingerprint
Dive into the research topics of 'Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy
Olaf Stuve, P. D. Cravens, Elliot Frohman, J. T. Phillips, G. M. Remington, G. Von Geldern, S. Cepok, M. P. Singh, J. W. Cohen Tervaert, M. De Baets, D. MacManus, D. H. Miller, E. W. Radü, E. M. Cameron, Nancy L Monson, Song Zhang, R. Kim, B. Hemmer, M. K. Racke
Research output: Contribution to journal › Article › peer-review
113
Scopus
citations